Marpai (MRAI) Q4 2025 earnings summary

Executive summary

• Revenue declined 36% year-over-year to $18.1 million, primarily due to a 28% customer attrition rate and market headwinds.

• Net loss improved to $16.6 million from $22.1 million in the prior year, reflecting cost reductions and operational streamlining.

• The company faces substantial doubt about its ability to continue as a going concern due to recurring losses, negative cash flows, and limited liquidity.

• Strategic operational realignment in early 2026 aims to consolidate claims processing and reduce workforce by 10%.

Financial highlights

• Revenue: $18.1 million in 2025 vs. $28.2 million in 2024 (down 36%).

• Net loss: $16.6 million in 2025 vs. $22.1 million in 2024 (improved by 25%).

• Operating loss: $13.6 million in 2025 vs. $22.1 million in 2024.

• Cash and cash equivalents: $133 thousand as of December 31, 2025.

• Accumulated deficit: $115.4 million as of December 31, 2025.

• Negative working capital: $15.4 million as of December 31, 2025.

Outlook and guidance

• Management expects to realize significant annualized operating expense savings from the 2026 restructuring.

• Additional capital is required to fund operations and capital investments until revenue growth enables self-sufficiency.

• If unable to raise capital, the company may be forced to scale back or divest assets.